In parallel, emerging immune-metabolic regulators such as IL27RA and TMEM71 have been identified through single-cell and integrative transcriptomic analyses as potential prognostic and therapeutic indicators in breast cancer [58, 59]. The gene discussed is IL27RA; the disease is breast carcinoma.